STAT1 and neoplasm: STAT1 encodes a protein that serves tumor-suppressive functions in many cancers and has been recognized as a potential biomarker for patient selection for treatment with anti-PD-1/anti-PD-L1 antibodies in breast cancer, as p-STAT1 correlates with higher PD-L1 and HLA class I expression [56,57].